Papers
1
Total Citations
65
H-Index
1
About
Hongbo Chen is a researcher whose work sits at the intersection of surgical oncology and evidence-based medicine, with a particular focus on prostate cancer treatment and minimally invasive surgical techniques. His most prominent contribution is a comprehensive systematic review and meta-analysis examining the comparative safety and efficacy of robotic-assisted radical prostatectomy (RARP) versus traditional retropubic radical prostatectomy (RRP) for prostate cancer, published in 2016 and accumulating 65 citations. This work addressed a critical and actively debated question in urological surgery by synthesizing data from large-scale, high-quality studies to provide clinicians with more robust, evidence-based guidance on surgical approach selection. By updating prior meta-analyses with newer and higher-quality trial data, Chen helped clarify the risk-benefit profile of emerging robotic surgical technology against the established gold standard, directly informing clinical decision-making for patients undergoing prostate cancer surgery. His research exemplifies the vital role of rigorous systematic methodology in evaluating surgical innovations, making his findings valuable to urologists, oncologists, and healthcare policymakers navigating the adoption of robotic surgery platforms in modern oncological practice.
Research Focus
Key Achievements
Top Papers
- 1